Announcing the 2022 HBA Board of Directors and Nominating Committee Leadership | HBA

Announcing the 2022 HBA Board of Directors and Nominating Committee Leadership

As the Healthcare Businesswomen's Association (HBA) works to close out a busy and successful 2021, we are proud to announce the leaders who will guide the organization in the new year.
 
The 2022 HBA board of directors and nominating committee were confirmed today at the HBA’s annual business meeting.

2022 HBA Global Board of Directors

Executive committee:

  • Chair: Shideh Sedgh Bina, Founding Partner, Insigniam
  • Vice-Chair: Julie Ross, President, Advanced Clinical
  • Secretary/Treasurer: Nicola Greenway, SVP, HR, Global Manufacturing Supply and Quality, Takeda Pharmaceutical Company

Directors at large:

  • Laura Butler, CEO, WorkLife Consulting, LLC
  • Anita Burrell, Founder, Anita Burrell Consulting LLC
  • Adam Dubow, Chief Compliance and Ethics Officer, Bristol Myers Squibb
  • Teresa Graham, Head, Global Product Strategy, Roche Pharmaceuticals
  • Michelle D. Greene, SVP and Chief Information Officer, Cardinal Health
  • Tamika Jean-Baptiste, VP, Global Diversity, Inclusion, and Belonging, Amgen, Inc.
  • Michelle Keefe, President, Commercial Solutions, Syneos Health
  • Carol Montandon, Global Chief Quality Officer and Worldwide VP Quality and Compliance, Johnson & Johnson
  • Jacquelyn Benton Moore, Healthcare Executive Director, Roche Genentech
  • Gisela Paulsen, Chief Operating Officer, Oncocyte Corporation
  • Keya Pitts MPH, VP, Global Safety Operations, Alnylam Pharmaceuticals, Inc.
  • Kathrin Schönborn-Sobolewski, VP, Planning, Analytics, and Partnering, Merck KGaA
  • Erik D. Smith, PhD, Principal, Strategy and Analytics, Deloitte Consulting
  • Mary Stutts, Global Chief Inclusion and Health Equity Officer, Real Chemistry
  • Jhaymee W. Tynan, Consultant, Global Health Practice and Diversity, Equity, and Inclusion Practice, Egon Zehnder
  • Dianne Yurek, SVP, Marketing, ConcertAI

2022 HBA Nominating Committee

  • Chair: Rebecca Vermeulen, VP, Patient and Society Strategy, Head of Healthcare and Patient Partnership Product Development, Genentech, a member of the Roche Group
  • Sheryl Fox, Founder and CEO, FutureHealth Strategies LLC
  • Ayanna Telfort, EVP, Director of Client Services, Razorfish Health
  • Sean Yap, Founder, Phenotype Global
  • Tint Tint Yap, VP, Integration, Separation, and Transition, Bayer

The incoming directors are inspired with their charge to continue the great work of the 2021 board, to champion the HBA’s mission to furthering the advancement and impact of women in the business of healthcare.

We are grateful and appreciative for the service of the 2021 HBA Board of Directors – those continuing their terms in 2022, and those committed advocates completing their terms this year.